{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:16:47Z","timestamp":1780334207299,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001791","name":"Griffith University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001791","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ijpddr.2020.10.010","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:59:58Z","timestamp":1604278798000},"page":"249-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-5725","authenticated-orcid":false,"given":"Eva","family":"Hesping","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina S.","family":"Skinner-Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian M.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine T.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2020.10.010_bib1","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/AAC.00729-08","article-title":"Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice","volume":"53","author":"Agbor-Enoh","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031847","article-title":"Comparative gene expression profiling of P. falciparum malaria parasites exposed to three different histone deacetylase inhibitors","volume":"7","author":"Andrews","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/icb.2011.97","article-title":"HDAC inhibitors in parasitic diseases","volume":"90","author":"Andrews","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib4","first-page":"3467","article-title":"Towards histone deacetylase inhibitors as new antimalarial drugs","volume":"18","author":"Andrews","year":"2012","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib5","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1128\/AAC.00757-07","article-title":"Potent antimalarial activity of histone deacetylase inhibitor analogues","volume":"52","author":"Andrews","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/156802609788085313","article-title":"Targeting histone deacetylase inhibitors for anti-malarial therapy","volume":"9","author":"Andrews","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib7","doi-asserted-by":"crossref","first-page":"D539","DOI":"10.1093\/nar\/gkn814","article-title":"PlasmoDB: a functional genomic database for malaria parasites","volume":"37","author":"Aurrecoechea","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib8","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1358\/dot.2009.45.11.1437052","article-title":"Romidepsin for the treatment of cutaneous T-cell lymphoma","volume":"45","author":"Campas-Moya","year":"2009","journal-title":"Drugs Today (Barc)."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib10","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/infdis\/jiv752","article-title":"Independent emergence of the Plasmodium falciparum kelch propeller domain mutant Allele C580Y in Guyana","volume":"213","author":"Chenet","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijpddr.2016.12.005","article-title":"Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth","volume":"7","author":"Chua","year":"2017","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib12","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/s41598-020-59298-4","article-title":"Epigenetic inhibitors target multiple stages of Plasmodium falciparum parasites","volume":"10","author":"Coetzee","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.chom.2014.06.014","article-title":"A Plasmodium falciparum histone deacetylase regulates antigenic variation and gametocyte conversion","volume":"16","author":"Coleman","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib14","doi-asserted-by":"crossref","first-page":"13143","DOI":"10.1073\/pnas.93.23.13143","article-title":"Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase","volume":"93","author":"Darkin-Rattray","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cell.2005.01.036","article-title":"Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum","volume":"121","author":"Duraisingh","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpddr.2015.05.004","article-title":"Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites","volume":"5","author":"Engel","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cbpa.2020.05.008","article-title":"Targeting histone acetylation\/deacetylation in parasites: an update (2017-2020)","volume":"57","author":"Fioravanti","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2005.01.037","article-title":"Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites","volume":"121","author":"Freitas-Junior","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib19","first-page":"4916","article-title":"FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases","volume":"62","author":"Furumai","year":"2002","journal-title":"Canc. Res."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40265-015-0388-8","article-title":"Panobinostat: first global approval","volume":"75","author":"Garnock-Jones","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bmcl.2014.12.051","article-title":"Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite","volume":"25","author":"Giannini","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib22","doi-asserted-by":"crossref","first-page":"29086","DOI":"10.1038\/srep29086","article-title":"A rational approach for the identification of non-hydroxamate HDAC6-selective inhibitors","volume":"6","author":"Goracci","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd2227","article-title":"Vorinostat","volume":"6","author":"Grant","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13072-017-0147-z","article-title":"Histone 4 lysine 8 acetylation regulates proliferation and host-pathogen interaction in Plasmodium falciparum","volume":"10","author":"Gupta","year":"2017","journal-title":"Epigenet. Chromatin"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib25","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1021\/acs.jmedchem.6b01595","article-title":"Lysine deacetylase inhibitors in parasites: past, present, and future perspectives","volume":"60","author":"Hailu","year":"2017","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.ijpddr.2020.10.010_bib26","article-title":"Dynamic chromatin structure and epigenetics control the fate of malaria parasites","volume":"S0168\u20139525","author":"Hollin","year":"2020","journal-title":"Trends Genet."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib27","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/febs.14376","article-title":"Genome-wide survey and phylogenetic analysis of histone acetyltransferases and histone deacetylases of Plasmodium falciparum","volume":"285","author":"Kanyal","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/icb.2011.100","article-title":"HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications","volume":"90","author":"Khan","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib30","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMc1612765","article-title":"Emergence of indigenous artemisinin-resistant Plasmodium falciparum in Africa","volume":"376","author":"Lu","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib31","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/cmdc.201800808","article-title":"Structure-activity and structure-toxicity relationships of peptoid-based histone deacetylase inhibitors with dual-stage antiplasmodial activity","volume":"14","author":"Mackwitz","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jmgm.2015.10.006","article-title":"Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors","volume":"62","author":"Melesina","year":"2015","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib33","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/EC.00114-07","article-title":"Plasmodium falciparum Sir2: an unusual sirtuin with dual histone deacetylase and ADP-ribosyltransferase activity","volume":"6","author":"Merrick","year":"2007","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.gene.2005.10.022","article-title":"The malaria parasite Plasmodium falciparum histones: organization, expression, and acetylation","volume":"369","author":"Miao","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2174\/1568011054866946","article-title":"Histone deacetylase inhibitors: latest developments, trends and prospects","volume":"5","author":"Moradei","year":"2005","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib36","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/acsmedchemlett.5b00468","article-title":"Discovery of a selective series of inhibitors of Plasmodium falciparum HDACs","volume":"7","author":"Ontoria","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib38","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2217\/fon.13.220","article-title":"Romidepsin for cutaneous T-cell lymphoma","volume":"9","author":"Prince","year":"2013","journal-title":"Future Oncol."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMc1705789","article-title":"Artemisinin-Resistant Plasmodium falciparum in Africa","volume":"377","author":"Rasmussen","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib40","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1073\/pnas.95.6.3003","article-title":"A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases","volume":"95","author":"Richon","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib41","first-page":"3637","article-title":"The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1\/WAF1 1","volume":"63","author":"Rosato","year":"2003","journal-title":"Canc. Res."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib42","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1182\/blood-2007-10-117762","article-title":"The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells","volume":"111","author":"Scuto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev.biochem.76.052705.162114","article-title":"Functions of site-specific histone acetylation and deacetylation","volume":"76","author":"Shahbazian","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib44","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1128\/AAC.00030-12","article-title":"Antimalarial activity of the anticancer histone deacetylase inhibitor SB939","volume":"56","author":"Sumanadasa","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib45","article-title":"Isozyme-selective activity of the HDAC inhibitor MS-275","volume":"64","author":"Tatamiya","year":"2004","journal-title":"Canc. Res."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib46","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2146\/news140056","article-title":"Belinostat approved for use in treating rare lymphoma","volume":"71","author":"Thompson","year":"2014","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib47","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1371\/journal.pbio.1000084","article-title":"Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum","volume":"7","author":"Tonkin","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib48","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1645\/0022-3395(2005)091[0484:HMPICC]2.0.CO;2","article-title":"Human malaria parasites in continuous culture. 1976","volume":"91","author":"Trager","year":"2005","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib49","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1073\/pnas.0408732102","article-title":"Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors","volume":"102","author":"Ungerstedt","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib50","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib51","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"7","key":"10.1016\/j.ijpddr.2020.10.010_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02523-19","article-title":"Activity of epigenetic inhibitors against Plasmodium falciparum asexual and sexual blood stages","volume":"64","author":"Vanheer","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib53","first-page":"971","article-title":"Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo","volume":"7","author":"Vigushin","year":"2001","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ijpddr.2020.10.010_bib54","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1126\/science.3299700","article-title":"Genetic analysis of the human malaria parasite Plasmodium falciparum","volume":"236","author":"Walliker","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ijpddr.2020.10.010_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/science.aap7847","article-title":"Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis","volume":"360","author":"Zhang","year":"2018","journal-title":"Science"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:50:18Z","timestamp":1761922218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320720300415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":55,"alternative-id":["S2211320720300415"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.10.010","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}